ArticleJournal of thoracic disease2026
Impact of socioeconomic determinants and clinical characteristics on non-small cell lung cancer survival: a real-world cohort study.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Data on clinical and socioeconomic factors affecting lung cancer survival in low-middle-income countries are limited. This study aims to explore the association between clinical, socioeconomic characteristics, and overall and cancer-specific survival in patients with lung cancer. Methods: A retrospective cohort of 16,038 patients with non-small cell lung cancer diagnosed between January 2000 and December 2016, with follow-up until December 2022. Eligible individuals were >18 years old with a histologically confirmed diagnosis. Variables included sociodemographic factors, cancer staging, imaging technology and facility density. Results: Independent predictors of all-cause mortality: gender, clinical stage, age, Human Development Index (HDI) 2010 {male Conclusions: Higher HDI score improves lung cancer survival in a middle-income country. Male gender, older age, and advanced stages predict poorer outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.